Pendapatan operasional sadurunge ngurangi amortisasi: Cryo-Cell International (CCEL)

Cryo-Cell International (CCEL) is implementing sustainable ESG standards in cryogenic storage, enhancing biodata security. Aggregated EBITDA demonstrates a daily cash inflow, with the current level sitting around 1.52. Profit growth is driven by the number of new contracts and the development of regenerative medicine. Stable annual client fees guarantee a predictable cash flow and eliminate liquidity gaps.

CCEL Bathi sadurunge mbayar bunga, pajak, lan amortisasi Cryo-Cell International (23.11.2025 - 11.11.2026)

Ringkesan rincian data analitis Cryo-Cell International, Inc. (CCEL)

- rega saham lan target rega konsensus:

Bagan rega Cryo-Cell|CCEL - Bagan rega target

- indikator kapitalisasi bursa perusahaan:

Kapitalisasi pasar Cryo-Cell International|CCEL - Nilai Perusahaan

- data ekuitas miturut neraca:

Nilai Akuntansi saben Saham Cryo-Cell International|CCEL - Nilai Buku Perusahaan|Nilai Pasar marang Nilai Buku cryo-cell.com|CCEL - Gunggung Aset Perusahaan

- rincian struktur utang lan likuiditas bisnis:

Utang marang Modal Cryo-Cell International|CCEL - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal Cryo-Cell|CCEL - Gunggung utang perusahaan|Utang marang aset resik Cryo-Cell International|CCEL - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Cryo-Cell International|Likuiditas darurat cryo-cell.com

- data bathi lan kelipatan valuasi:

CCEL - Bathi resik perusahaan|Bathi sing dikarepake Cryo-Cell International|CCEL - Rasio rega marang bathi|Rega marang bathi mangsa ngarep Cryo-Cell|CCEL - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Cryo-Cell International|CCEL - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Cryo-Cell International|CCEL - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan cryo-cell.com|CCEL - Wutah bathi resik saben saham ing taun iki|Proyeksi tambahing bathi saben saham ing taun ngarep Cryo-Cell International

Pambiji fundamental perusahaan:CCEL, Cryo-Cell International

This indicator measures the actual cash flow generated by operating activities during a period of expensive liquidity and tight monetary policy. By analyzing the EBITDA of Cryo-Cell International (CCEL) on the GURU.Markets platform, an investor assesses the business's resilience to high interest rates, which for Cryo-Cell International (CCEL) is confirmed by the stability of its core biochemist team and low attrition among specialized professionals.

Karo sapa Cryo-Cell International saingan

Mesoblast Pharma - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|LCTX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan operasional sadurunge ngurangi amortisasi surrozen.com SRZN|FBLG: Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi Longeveron Inc|Bathi sadurunge mbayar bunga, pajak, lan amortisasi BioRestorative Therapies Inc|CELZ: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi